Search

Your search keyword '"Chrysikos, Serafeim"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Chrysikos, Serafeim" Remove constraint Author: "Chrysikos, Serafeim"
111 results on '"Chrysikos, Serafeim"'

Search Results

1. Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

2. Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis

3. Efficacy of inhaled tobramycin in adult patients with bronchiectasis and P. aeruginosa in sputum: a prospective observational study

4. Comparison of effectiveness between baricitinib and tocilizumab in severe COVID-19. A retrospective study.

7. Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model

8. A 68-Year-Old Patient With Dyspnea and Hypoxemia After Total Hip Arthroplasty.

9. Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model

10. Clinical features and outcomes of patients with myositis associated-interstitial lung disease

12. Diagnostic Accuracy of Multiple D-Dimer Cutoff Thresholds and Other Clinically Applicable Biomarkers for the Detection and Radiographic Evaluation of Pulmonary Embolism

13. Predictors of Mortality in Tocilizumab-Treated Severe COVID-19

14. Differential expression of PD-1/PD-L1 axis in mediastinal lymph nodes of experimental and human lung fibrosis

15. Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model

16. Differential expression of PD-1/PD-L1 axis and CD4/CD8 ratio in mediastinal lymph nodes of patients with idiopathic pulmonary fibrosis and lung cancer

17. Pulmonary Embolism: Incidence, spectrum of CTPA findings, and correlation of D-dimers with embolus location. Is age-adjusted D-dimers cutoff a better screening method?

19. Clinical features and outcomes of patients with myositis associated-interstitial lung disease

20. Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases

21. Epidemiological Characteristics and Outcomes from 187 Patients with COVID-19 Admitted to 6 Reference Centers in Greece: An Observational Study during the First Wave of the COVID-19 Pandemic

22. Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases

23. Clinical features and outcomes of patients with myositis associated-interstitial lung disease

24. Additional file 1 of Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

25. Η κλινική σημασία της PET/CT ποζιτρονικής απεικόνισης του μεσοθωρακίου σε σχέση με τον συνδυασμένο ενδοσκοπικό υπέρηχο (EBUS-TBNA και EUS-FNA) σε ασθενείς με μη μικροκυτταρικό καρκίνο πνεύμονα

26. The role of increased red cell distribution width as a negative prognostic marker in patients with COPD

29. Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model.

31. Clinical utility of thoracic endosonography (EBUS/EUS-b) in mediastinal staging of patients with non-small cell lung cancer: comparison with integrated PET/CT—a real-life prospective study in Greece

33. Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Hypersensitivity Pneumonitis

35. Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC

36. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece

38. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study

39. Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study

40. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study

44. Thoracic endosonography (EBUS/EUS‐b) in the diagnosis of different intrathoracic diseases: A 4‐year experience at a single‐centre in Greece.

46. Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study

47. Bronchiectasis contributes to the severity of COPD

48. A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass

49. Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

50. Metabolic Disorders in Chronic Lung Diseases

Catalog

Books, media, physical & digital resources